Skip to main content

Find Clinical Trials

Home
Conditions
Digestive System Neoplasms

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,337 public trials 3,266 recruiting studies

Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Not yet recruiting

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

NCT07025239

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer

NCT07021950

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence

NCT06954116

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not yet recruiting

Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma

NCT07019181

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +7 more
Locations: Not specified

View Trial Details

Not yet recruiting

Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study.

NCT06646445

Conditions: Colon Cancer, Colonic Diseases, Colonic Neoplasms, +14 more
Locations: Institut Sainte Catherine Avignon, France

CHU Besançon Besançon, France

IHFB Cognacq Jay Levallois-Perret, France

Centre Leon Berard Lyon, France

View Trial Details

Not yet recruiting

Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer

NCT07018063

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric (Cardia, Body) Cancer, +8 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

Impact of GLP-1 Receptor Agonists on Patients With IPMN

NCT07014709

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +14 more
Locations: HFR Hopital fribourgeois Villars-sur-Glâne, Switzerland

View Trial Details

Not yet recruiting

Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk

NCT07010588

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

The First Affiliated Hospital of Army Medical University Chongqing, Chongqing Municipality, China

Handan Central Hospital Handan, Hebei, China

Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

View Trial Details

Not yet recruiting

QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC

NCT07009145

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
Locations: The First Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China

View Trial Details

Not yet recruiting

Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis

NCT07007728

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Peking University Cancer Hospital & Institute Beijing, Beijing Municipality, China

View Trial Details